Nodal检测双单抗夹心ELISA法建立及应用

doi:10.13523/j.cb.20170307

中国生物工程杂志

2017, Vol. 37

Issue (3): 51-57 DOI: 10.13523/j.cb.20170307

技术与方法

Nodal检测双单抗夹心ELISA法建立及应用

吴孟玲, 周嘉旺, 杜军

中山大学药学院微生物与生化药学实验室广州 510006

Development and Application of A Double Monoclonal Antibody Sandwich ELISA for the Assay of Nodal

WU Meng-ling, ZHOU Jia-wang, DU Jun

Department of Microbial and Biochemical Pharmacy, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China

全文: PDF(878 KB) HTML

摘要：

现已证实，Nodal参与了肿瘤恶性生物学过程，但对其高敏感检测法尚未建立。采用基因工程表达人源Nodal作为抗原免疫BALB/c小鼠，通过经典PEG诱导的细胞融合技术筛选出针对Nodal的特异性单克隆抗体7株。夹心ELISA确证7株抗体组成了15种可配对的抗体对。经筛选后选取抗体对AF12-DG5建立标准化夹心ELISA法，结合生物素-亲和素检测系统，DG5抗体标记生物素，采用链亲和素与辣根过氧化物酶标记的生物素（HRP-Biotin）按质量比4：1预先混合孵育的ABC混合物进行检测，以提高ELISA法的灵敏度。棋盘滴定确定抗体工作最佳浓度为：捕获抗体（AF12）2μg/ml，检测抗体（生物素化DG5）2μg/ml。此条件下的夹心ELISA法线性范围为0~3 000pg/ml，检测限为68pg/ml，平均回收率为99.6%，精密度准确度良好。以正常人血清作为阴性对照，使用该夹心ELISA法测定结直肠癌、鼻咽癌和胆囊癌患者血清，发现三种肿瘤患者血清与正常人血清中的Nodal浓度均存在明显的统计学差异，可作为临床使用参考。

关键词： Nodal; 配对抗体; 生物素-亲和素; 双抗夹心ELISA; 细胞融合

Abstract:

Background:Nodal is a member of the transforming growth factor beta (TGF-beta) super family, essential in maintaining the pluripotency of human embryonic stem cells (hESCs), which is not active in most adult tissues, its reexpression and signaling have been linked to multiple types of human cancer. Recent findings have revealed that Nodal is a critical regulator of melanoma growth, plasticity and tumorigenicity, and holds promise as a new tumor biomarker. Similar observations have been reported in multiple human cancers. To utilize Nodal as a useful biomarker for cancer detection, a double monoclonal antibody sandwich enzyme-linked immunosorbent assay (ELISA) may be a reliable, easy and cheap means. Methodology/principal findings:Recombinant Nodal was used as antigen to immunize BALB/c mice, by cell fusion between plasma cells and SP2/0 cells, 7 specific positive monoclonal antibodies were picked out, which were verified through indirect ELISA, Western blot and flow cytometry analyses. Therefore 15 pairs of antibodies can be used to set up a double monoclonal antibody sandwich ELISA, AF12-DG5 was the most appropriate antibody pairs. Combined with biotin-avidin systerm, DG5-biotin was used as detection antibody while the complex of streptavidin and HRP-biotin (mass ratio 4:1) as detection reagent. The best working concentration of antibodies were AF12 2μg/ml and DG5-biotin 2μg/ml. Linear range of this ELISA is 0~3 000pg/ml, regression equation is y=0.000 3x+0.150 5,R²=0.999, low limit of detection is 68pg/ml, average recovery is 99.6%. The result of serum detection indicates that more Nodal was expressed in 70% of gallbladder carcinoma patients, 92% of nasopharyngeal carcinoma patients and 97% of colorectal carcinoma patients, which were statistically significantly increased compare to normal human.Conclusions/significance:A sensitive and specific Nodal ELISA test has been developed. This test is high sensitive and easy to use and can discriminate cancer patients from normal person specifically. The achieved data suggest that the developed ELISA may be applicable as a research tool for detection of human cancer.

Key words: Double antibody sandwich ELISA Biotin-avidin Cell fusion techniques Nodal Monoclonal antibody

收稿日期: 2016-12-26 出版日期: 2017-03-25

ZTFLH:

Q816

基金资助:

国家自然科学基金资助项目（81672943、81472643）

通讯作者: 杜军 E-mail: dujun@mail.sysu.edu.cn

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

引用本文:

吴孟玲, 周嘉旺, 杜军. Nodal检测双单抗夹心ELISA法建立及应用[J]. 中国生物工程杂志, 2017, 37(3): 51-57.

WU Meng-ling, ZHOU Jia-wang, DU Jun. Development and Application of A Double Monoclonal Antibody Sandwich ELISA for the Assay of Nodal. China Biotechnology, 2017, 37(3): 51-57.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20170307 或 https://manu60.magtech.com.cn/biotech/CN/Y2017/V37/I3/51

[1] Conleyba T S. Prognostic and predictive markers in cancer. DIS Markers, 2004, 20(2):35-43.
[2] Sturgeon C. Practice guidelines for tumor marker use in the clinic. Clinical Chemistry, 2002, 48(8):1151-1159.
[3] 杨立新,郁卫东,刘桂生,等.Nodal信号的研究进展.中国生物工程杂志,2003,23(3):15-19. Yang L X, Yu W D, Liu G S, et al. Recent advances in nodal signaling. China Biotechnology, 2003,23(3):15-19.
[4] Seo H J, Kim Y J, Cho K B, et al. Nodal metastasis after successful endoscopic submucosal dissection for colorectal mucosal cancer. Endoscopy, 2011, 43(Suppl 2 UCTN):E374-E375.
[5] Quail D F, Walsh L A, Zhang Gui-hua, et al. Embryonic protein nodal promotes breast cancer vascularization. Cancer Research, 2012, 72(15):3851-3863.
[6] 方瑞,杜军.Nodal信号调控与肿瘤的研究现状.中华肿瘤防治杂志,2012,19(11):872-876. Fang R, Du J. Research advances of regulation of Nodal signal and tumor. Chinese Journal of Cancer Prevention and Treatment, 2012,19(11):872-876.
[7] Strizzi L, Hardy K M, Kirschmann D A, et al. Nodal expression and detection in cancer:experience and challenges. Cancer Research, 2012, 72(8):1915-1920.
[8] Engvall E, Karin J, Perlmann P. Enzyme-linked immunosorbent assay. II. Quantitative assay of protein antigen, immunoglobulin G, by means of enzyme-labelled antigen and antibody-coated tubes. Biochimica ET Biophysica ACTA (Bba)-Protein STRU, 1971, 251(3):427-434.
[9] Zangar R C, Daly D S, White A M. ELISA microarray technology as a high-throughput system for cancer biomarker validation. Expert Review of Proteomics, 2006, 3(1):37-44.
[10] Gan S D, Patel K R. Enzyme immunoassay and enzyme-linked immunosorbent assay. Journal of Investigative Dermatology, 2013, 133(9):1-3.
[11] 李玲玲,江冠民,张革,等.人源Nodal成熟肽的原核表达及多克隆抗体的制备.细胞与分子免疫学杂志,2011,27(8):880-882,88. Li L L, Jiang G M, Zhang G, et al. Prokaryotic expression and polyclonal antibody preparation of human Nodal mature peptide. Journal of Cellular and Molecular Immunology, 2011,27(8):880-882,88.
[12] 陈万青,张思维,曾红梅,等.中国2010年恶性肿瘤发病与死亡.中国肿瘤,2014,23(1):1-10. Chen M Q, Zhang S W, Zeng H M et al. Report of cancer incidence and mortality in China,2010. Bulletin of Chinese Cancer, 2014,23(1):1-10.
[13] Lech G, Ssotw n' ski R, Sodkowski M, et al. Colorectal cancer tumour markers and biomarkers:recent therapeutic advances. World Journal of Gastroenterology, 2016,22(5):1745-1755.
[14] Goulart B L, Clark J W, Pien H H, et al. Trends in the use and role of biomarkers in phase I oncology trials. Clinical Cancer Research, 2007, 13(22):6719-6726.
[15] Hsu S M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques a comparison between ABC and unlabeled antibody (PAP) procedures. The Journal of Histochemistry and Cytochemistry, 1981, 29(4):577-580.
[16] Grumbach I M, Veh R W. The SA rABC technique a new ABC procedure for detection of antigens at increased sensitivity. The Journal of Histochemistry and Cytochemistry, 1995, 43(1):31-37.

[1]	刘俊伟, 常瑞恒, 回鹏, 董士尚, 王金凤, 孙波, 杨诚. 抗埃博拉病毒核蛋白抗体的制备与双抗夹心ELISA检测方法的建立[J]. 中国生物工程杂志, 2017, 37(10): 53-59.
[2]	权美玉, 郭强, 张坤水, 方瑞, 李翠琳, 杜军. *稳定高表达和干扰Nodal基因黑色素瘤细胞株构建及EMT表型鉴定*[J]. 中国生物工程杂志, 2014, 34(3): 1-8.
[3]	李孜, 包欣晨, 高向东, 陆小冬, 徐晨. OAS1蛋白单克隆抗体的制备及其表征[J]. 中国生物工程杂志, 2011, 31(10): 7-11.
[4]	凌树宽,李莹辉,戴钟铨,杨芬,聂捷琳. 骨髓间质干细胞修复受损心肌研究进展[J]. 中国生物工程杂志, 2007, 27(6): 107-110.
[5]	杨立新, 郁卫东, 刘桂生, 陈清轩. Nodal信号的研究进展[J]. 中国生物工程杂志, 2003, 23(3): 15-19.
[6]	黄镇亚. 木材成分的生物分解与生物工程[J]. 中国生物工程杂志, 1991, 11(1): 35-38.
[7]	竹林. 杂交瘤形成方法[J]. 中国生物工程杂志, 1990, 10(4): 58-59.
[8]	. 日本工业界的研究开发活动[J]. 中国生物工程杂志, 1988, 8(S1): 50-57.
[9]	. 日本2000年生物技术发展预测[J]. 中国生物工程杂志, 1988, 8(S1): 58-61.
[10]	李向辉. 植物遗传操作技术的发展[J]. 中国生物工程杂志, 1988, 8(3): 11-16.
[11]	任玉岭. 生物技术在中国[J]. 中国生物工程杂志, 1988, 8(1): 16-22.
[12]	卢圣栋, 顾方舟. 生物技术与医学科学[J]. 中国生物工程杂志, 1988, 8(1): 34-38.
[13]	卢继传. 人工操纵生命的伟大业绩[J]. 中国生物工程杂志, 1988, 8(1): 47-50.
[14]	张震元. 日本用基因重组技术生产色氨酸的进展[J]. 中国生物工程杂志, 1987, 7(5): 75-75.
[15]	赵惠智. 高级基因转移系统和方法[J]. 中国生物工程杂志, 1987, 7(3): 58-59.

Viewed

Full text

Abstract

Cited

Shared

Discussed